---
created: 2025-04-13
updated: 2025-04-13T10:53
id: bYj1nUTn?C
specialty: cardio
specialty_id: 435
tags:
  - source/ak-original-decks::step-1::zanki-step-decks::zanki-cardiovascular::cardio-pathology
  - source/ak-step1-v11::!flag-these-cards::sketchypathadds
  - "source/ak-step1-v11:": 
  - theme/firstaid::07-cardiovascular::04-pathology::11-ischemic-heart-disease::transient-myocardial-ischemia
  - "source/ak-step1-v11:": 
  - theme/nbme::26
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::09-cardiac
  - "source/ak-step1-v11:": 
  - theme/sketchypath::01-cardiac::01-ischemic-heart-disease::02-stable-angina,-vasospastic-angina,-&-acute-coronary-syndromes-(ua,-nstemi,-stemi)
  - source/ak-step1-v11::^other::^expn::jbadd
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield
  - source/ak-step1-v11::^systems::cardio::jbadds
type: flashcard
---

# Question
Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor lowers morbidity and mortality rates in patients with **NSTEMIs**

---

# Answer
- Dual antiplatelet therapy with, eg, clopidogrel, should be administered to all patients with no contraindications (e.g. allergy, bleeding) * Nitroglycerin is used to treat chest pain in patients with ACS but has no added mortality benefit